STXS
Stereotaxis, Inc. · Healthcare · Market cap $129.3M
Insider Buying
$67K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jul 1, 2026
Isaac Paul J
Stereotaxis, Inc. (STXS) has 13 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 1, 2026.
Inside the rolling window, 1 insider at Stereotaxis, Inc. reported 2 open-market purchases totaling $67K and no open-market sales. The most recent open-market filing is a purchase of 20,000 shares by Director Isaac Paul J, dated Nov 14, 2025, worth $45K.
- Industry:Medical - Equipment & Services
- CEO:David L. Fischel
- Employees:131
- HQ:St. Louis, MO, US
- IPO:2004-08-12
| Source | |||||||
|---|---|---|---|---|---|---|---|
Isaac Paul JFirst filing | See Remarks | Purchase | 20,000 | $45K | Nov 18 | -43.7% | SEC ↗ |
Isaac Paul JFirst filing | See Remarks | Purchase | 10,000 | $22K | Nov 18 | -43.7% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does STXS have?
Stereotaxis, Inc. (STXS) has 13 SEC Form 4 filings (14 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 1, 2026.
When was the most recent SEC Form 4 filing for STXS?
The most recent Form 4 filing for STXS on Tracefour is dated Jul 1, 2026.
What is the total insider buy and sell value at STXS in the current window?
Inside the rolling window, insiders at STXS bought $67K and sold $0 based on SEC Form 4 filings.
Can I get alerts for STXS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Stereotaxis, Inc. (STXS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Stereotaxis, Inc. is in the Healthcare sector.